Survival Rate

"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.

Descriptor ID	D015996
MeSH Number(s)	E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
Concept/Terms	Survival Rate Survival Rate Rate, Survival Rates, Survival Survival Rates Mean Survival Time Mean Survival Time Mean Survival Times Survival Time, Mean Survival Times, Mean Time, Mean Survival Times, Mean Survival Cumulative Survival Rate Cumulative Survival Rate Cumulative Survival Rates Rate, Cumulative Survival Rates, Cumulative Survival Survival Rate, Cumulative Survival Rates, Cumulative

Below are MeSH descriptors whose meaning is more general than "Survival Rate".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Data Collection [E05.318.308]
Vital Statistics [E05.318.308.985]
Mortality [E05.318.308.985.550]
Survival Rate [E05.318.308.985.550.900]
Health Care [N]
Population Characteristics [N01]
Demography [N01.224]
Vital Statistics [N01.224.935]
Mortality [N01.224.935.698]
Survival Rate [N01.224.935.698.826]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Measurements [N06.850.505]
Demography [N06.850.505.400]
Vital Statistics [N06.850.505.400.975]
Mortality [N06.850.505.400.975.550]
Survival Rate [N06.850.505.400.975.550.900]
Epidemiologic Methods [N06.850.520]
Data Collection [N06.850.520.308]
Vital Statistics [N06.850.520.308.985]
Mortality [N06.850.520.308.985.550]
Survival Rate [N06.850.520.308.985.550.900]

Below are MeSH descriptors whose meaning is related to "Survival Rate".

Below are MeSH descriptors whose meaning is more specific than "Survival Rate".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.

Bar chart showing 340 publications over 26 distinct years, with a maximum of 36 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	1	1
1997	0	1	1
1999	0	1	1
2000	1	1	2
2001	0	2	2
2002	0	11	11
2003	0	14	14
2004	0	19	19
2005	0	17	17
2006	0	24	24
2007	0	33	33
2008	0	26	26
2009	0	27	27
2010	0	27	27
2011	0	36	36
2012	0	18	18
2013	0	14	14
2014	0	10	10
2015	0	11	11
2016	0	9	9
2017	0	18	18
2018	0	8	8
2019	0	4	4
2020	0	3	3
2021	0	3	3
2022	0	1	1

Below are the most recent publications written about "Survival Rate" by people in Profiles.

Keith SW, Maio V, Arafat HA, Alcusky M, Karagiannis T, Rabinowitz C, Lavu H, Louis DZ. Angiotensin blockade therapy and survival in pancreatic cancer: a population study. BMC Cancer. 2022 Feb 07; 22(1):150.

View in: PubMed
Horgan R, Youssef JA, Levy AT, Berger SI, Dreux S, Brizot ML, Boutall A, Abuhamad AZ, Angarita AM, Al-Kouatly HB. Etiology and Outcome of Isolated Fetal Ascites: A Systematic Review. Obstet Gynecol. 2021 12 01; 138(6):897-904.

View in: PubMed
Gong Y, Nagarathinam R, Arisi MF, Gerratana L, Winn JS, Slifker M, Pei J, Cai KQ, Hasse Z, Obeid E, Noriega J, Sebastiano C, Ross E, Alpaugh K, Cristofanilli M, Fernandez SV. Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC). Int J Mol Sci. 2021 Aug 19; 22(16).

View in: PubMed
Liu D, Augello MA, Grbesa I, Prandi D, Liu Y, Shoag JE, Karnes RJ, Trock BJ, Klein EA, Den RB, Demichelis F, Davicioni E, Sboner A, Barbieri CE. Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer. J Clin Invest. 2021 05 17; 131(10).

View in: PubMed
Lutfi W, Martinez-Meehan D, Sultan I, Evans N, Dhupar R, Luketich JD, Christie NA, Okusanya OT. Racial disparities in local therapy for early stage non-small-cell lung cancer. J Surg Oncol. 2020 Dec; 122(8):1815-1820.

View in: PubMed
Kim AH, Tatter S, Rao G, Prabhu S, Chen C, Fecci P, Chiang V, Smith K, Williams BJ, Mohammadi AM, Judy K, Sloan A, Tovar-Spinoza Z, Baumgartner J, Hadjipanayis C, Leuthardt EC. Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN): 12-Month Outcomes and Quality of Life After Brain Tumor Ablation. Neurosurgery. 2020 09 01; 87(3):E338-E346.

View in: PubMed
Pomponio MK, Burkbauer L, Goldbach M, Nazarian SM, Xie F, Clark AS, Matro JM, Fox KR, Shulman LN, Keele LJ, Tchou J. Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience. J Surg Oncol. 2020 Mar; 121(3):447-455.

View in: PubMed
Sada A, Asaad M, Bews KA, Thompson GB, Young WF, Bancos I, Farley DR, Dy BM, Lyden ML, Habermann EB, McKenzie TJ. Comparison between functional and non-functional adrenocortical carcinoma. Surgery. 2020 01; 167(1):216-223.

View in: PubMed
Courtwright AM, Zaleski D, Tevald M, Adler J, Singer JP, Cantu EE, A Bermudez C, Diamond JM. Discharge frailty following lung transplantation. Clin Transplant. 2019 10; 33(10):e13694.

View in: PubMed
Goodman AM, Sokol ES, Frampton GM, Lippman SM, Kurzrock R. Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy. Cancer Immunol Res. 2019 10; 7(10):1570-1573.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement